190 related articles for article (PubMed ID: 24165277)
1. Detection of lamivudine-resistant variants and mutations related to reduced antigenicity of HBsAg in individuals from the cities of Santos and São Paulo, Brazil.
Mantovani N; Cicero M; Santana LC; Silveira C; do Carmo EP; Abrão PR; Diaz RS; Caseiro MM; Komninakis SV
Virol J; 2013 Oct; 10():320. PubMed ID: 24165277
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the
Arikan A; Sayan M; Sanlidag T; Suer K; Akcali S; Guvenir M
Pol J Microbiol; 2019 Sep; 68(3):317-322. PubMed ID: 31880877
[TBL] [Abstract][Full Text] [Related]
3. Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene.
Torresi J; Earnest-Silveira L; Civitico G; Walters TE; Lewin SR; Fyfe J; Locarnini SA; Manns M; Trautwein C; Bock TC
Virology; 2002 Jul; 299(1):88-99. PubMed ID: 12167344
[TBL] [Abstract][Full Text] [Related]
4. HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia.
Belyhun Y; Maier M; Liebert UG
Antivir Ther; 2017; 22(2):97-111. PubMed ID: 27354181
[TBL] [Abstract][Full Text] [Related]
5. [HBV pol/S gene mutations in chronic hepatitis B patients receiving nucleoside/nucleotide analogues treatment].
Kırdar S; Yaşa MH; Sayan M; Aydın N
Mikrobiyol Bul; 2019 Apr; 53(2):144-155. PubMed ID: 31130119
[TBL] [Abstract][Full Text] [Related]
6. New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H.
Fernández-Galindo DA; Sánchez-Ávila F; Bobadilla-Morales L; Gómez-Quiróz P; Bueno-Topete M; Armendáriz-Borunda J; Sánchez-Orozco LV
J Med Virol; 2015 Jun; 87(6):985-92. PubMed ID: 25732900
[TBL] [Abstract][Full Text] [Related]
7. [HBV vaccine escape mutations in a chronic hepatitis B patient treated with nucleos(t)ide analogues].
Sayan M; Buğdacı MS
Mikrobiyol Bul; 2013 Jul; 47(3):544-9. PubMed ID: 23971933
[TBL] [Abstract][Full Text] [Related]
8. HBV carrying drug-resistance mutations in chronically infected treatment-naive patients.
Gomes-Gouvêa MS; Ferreira AC; Teixeira R; Andrade JR; Ferreira AS; Barros LM; Rezende RE; Nastri AC; Leite AG; Piccoli LZ; Galvan J; Conde SR; Soares MC; Kliemann DA; Bertolini DA; Kunyoshi AS; Lyra AC; Oikawa MK; de Araújo LV; Carrilho FJ; Mendes-Corrêa MC; Pinho JR
Antivir Ther; 2015; 20(4):387-95. PubMed ID: 25624410
[TBL] [Abstract][Full Text] [Related]
9. Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B.
Coppola N; Tonziello G; Colombatto P; Pisaturo M; Messina V; Moriconi F; Alessio L; Sagnelli C; Cavallone D; Brunetto M; Sagnelli E
J Infect; 2013 Oct; 67(4):322-8. PubMed ID: 23796869
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology and genotyping of hepatitis B virus of HBsAg-positive patients in Oman.
Al Baqlani SA; Sy BT; Ratsch BA; Al Naamani K; Al Awaidy S; Busaidy SA; Pauli G; Bock CT
PLoS One; 2014; 9(5):e97759. PubMed ID: 24835494
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus.
Wakil SM; Kazim SN; Khan LA; Raisuddin S; Parvez MK; Guptan RC; Thakur V; Hasnain SE; Sarin SK
J Med Virol; 2002 Nov; 68(3):311-8. PubMed ID: 12226816
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and chronicity of acute hepatitis B induced by lamivudine-resistant strains.
Luo Q; Zhong Y; Yang Y; Xiong Q; Hu Z; Lu W; Huang P; Zhang N
J Med Virol; 2012 Oct; 84(10):1558-61. PubMed ID: 22930503
[TBL] [Abstract][Full Text] [Related]
14. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
Ohkawa K; Takehara T; Kato M; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
J Infect Dis; 2008 Oct; 198(8):1150-8. PubMed ID: 18713056
[TBL] [Abstract][Full Text] [Related]
15. Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B.
Cha CK; Kwon HC; Cheong JY; Cho SW; Hong SP; Kim SO; Yoo WD
J Med Virol; 2009 Mar; 81(3):417-24. PubMed ID: 19152409
[TBL] [Abstract][Full Text] [Related]
16. Sequence analysis of the polymerase gene in hepatitis B virus infected blood donors in Iran.
Sharifi Z; Yari F; Gharebaghiyan A
Arch Iran Med; 2012 Feb; 15(2):88-90. PubMed ID: 22292578
[TBL] [Abstract][Full Text] [Related]
17. Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B.
Iacomi F; Vincenti D; Vairo F; Solmone M; Mariano A; Piselli P; Puro V; Capobianchi MR; Antonucci G
J Med Virol; 2009 Jul; 81(7):1151-6. PubMed ID: 19475624
[TBL] [Abstract][Full Text] [Related]
18. High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates.
Neumann-Fraune M; Beggel B; Pfister H; Kaiser R; Verheyen J
J Med Virol; 2013 May; 85(5):775-9. PubMed ID: 23408582
[TBL] [Abstract][Full Text] [Related]
19. HBV mutations associated with lamivudine therapy.
Lapiński TW; Parfieniuk-Kowerda A; Trzos A; Jaroszewicz J; Kowalczuk O; Nikliński J; Flisiak R
Przegl Epidemiol; 2013; 67(4):611-6, 705-8. PubMed ID: 24741905
[TBL] [Abstract][Full Text] [Related]
20. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ
J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]